Not too long ago, liver disease was difficult to diagnose and almost impossible to treat. But today, treatment options are more plentiful, better targeted and more effective, improving the lives of people with liver disease.

Albert Einstein Center for Liver Disease offers patients the latest in medications, interventional procedures and new surgical and transplantation options. Our commitment to quality and our surgeons' and doctors' superior skills help ensure successful treatment for patients.

Einstein's Liver Surgery and Transplantation Program is one of the region's largest programs–attracting patients from the Delaware Valley region and other countries around the world. The surgical team performs approximately 50 liver transplants each year and hundreds of non-transplant liver procedures and operations.

Einstein's liver surgeons use the latest transplantation advances safely and effectively including reduced sizes, split liver transplantations and extended donors. At 87 percent, survival rates of patients who undergo liver transplantation at Albert Einstein Medical Center are higher than the national average of 80 percent. The average Intensive Care Unit stay for patients receiving a liver transplant is two days

Along with the advances in medical management of liver disease, surgeons now have new guidelines for choosing transplantation as a treatment option for liver cancer,
Hepatitis B and Hepatitis C, among others.

Einstein's liver transplantation program has been approved for Medicare since 1997, after meeting stringent standards for survival rates and services offered.

Information on the HBV Program from the American Liver Foundation.